⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4669859 | 1.00 | — | — | |
| SCHEMBL1720682 | 1.00 | — | — | |
| SCHEMBL6704381 | 0.84 | — | — | |
| SCHEMBL28136059 | 0.82 | CCR2 (0.46) | — | |
| SCHEMBL198981 | 0.82 | — | — | |
| SCHEMBL1688449 | 0.80 | CCR2 (0.49) | — | |
| SCHEMBL2080301 | 0.74 | — | — | |
| SCHEMBL1457363 | 0.69 | — | — | |
| SCHEMBL10211406 | 0.67 | — | — | |
| SCHEMBL1937007 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE46942-E1 | 4-piperidinyl compounds for use as tankyrase inhibitors | NOVARTIS AG (CH) | 2018-07-10 | — | — | US | disclosed |
| US-RE46942-E1 | 4-piperidinyl compounds for use as tankyrase inhibitors | NOVARTIS AG (CH) | 2018-07-10 | — | — | US | disclosed |
| US-9163003-B2 | 4-piperidinyl compounds for use as tankyrase inhibitors | NOVARTIS AG (CH) | 2015-10-20 | — | — | US | disclosed |
| US-9163003-B2 | 4-piperidinyl compounds for use as tankyrase inhibitors | NOVARTIS AG (CH) | 2015-10-20 | — | — | US | disclosed |
| EP-2731940-B1 | 4 - PIPERIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS | NOVARTIS AG (CH) | 2015-08-19 | — | — | EP | disclosed |
| US-20150126513-A1 | 4-PIPERIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS | NOVARTIS AG (CH) | 2015-05-07 | — | — | US | disclosed |
| US-20150126513-A1 | 4-PIPERIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS | NOVARTIS AG (CH) | 2015-05-07 | — | — | US | disclosed |
| WO-2013008217-A1 | 4 - PIPERIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS | NOVARTIS AG (CH) | 2013-01-17 | — | — | WO | disclosed |
| EP-1193253-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AZETIDINE-2-CARBOXYLIC ACIDS | KANEKA CORP (JP) | 2008-06-25 | — | — | EP | disclosed |
| EP-1927588-A2 | Process for producing optically active azetidine-2-carboxylic acids | KANEKA CORPORATION (JP) | 2008-06-04 | — | — | EP | disclosed |
| US-7262308-B2 | Process for producing optically active azetidine-2-carboxylic acids | KANEKA CORPORATION (JP) | 2007-08-28 | — | — | US | disclosed |
| US-20050043547-A1 | Process for producing optically active azetidine-2-carboxylic acids | HONDA TATSUYA (JP) | 2005-02-24 | — | — | US | disclosed |
| US-6838567-B1 | Process for producing optically active azetidine-2-carboxylic acids | KANEKA CORPORATION (JP) | 2005-01-04 | — | — | US | disclosed |
| EP-1170287-B1 | PROCESS FOR PREPARATION OF OPTICALLY ACTIVE N-SUBSTITUTED AZETIDINE-2-CARBOXYLIC ACIDS | KANEKA CORP (JP) | 2003-12-03 | — | — | EP | disclosed |
| US-6617461-B2 | Cyclizing an optically active 4-substituted amino-2-halobutyric acid containing substituted oxycarbonyl or sulfonyl type protective group in presence of a base | KANEKA CORPORATION (JP) | 2003-09-09 | — | — | US | disclosed |
| US-20030045730-A1 | Process for preparation of optically active n-substituted azetidine-2-carboxylic acids | KANEKA CORPORATION (JP) | 2003-03-06 | — | — | US | disclosed |
| EP-1193253-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AZETIDINE-2-CARBOXYLIC ACIDS | KANEKA CORPORATION (JP) | 2002-04-03 | — | — | EP | disclosed |
| EP-1170287-A1 | PROCESS FOR PREPARATION OF OPTICALLY ACTIVE N-SUBSTITUTED AZETIDINE-2-CARBOXYLIC ACIDS | KANEKA CORPORATION (JP) | 2002-01-09 | — | — | EP | disclosed |